Viewing nowLipidu Tablets (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

MFDS item code 200301662 · Notified 2003.10.20 · Insurance code 644700550
Improvement of hyperlipidemia (including familial hyperlipidemia in children) and prevention of cardiovascular disease
This medication helps reduce the risk of death from coronary heart disease and the risk of nonfatal myocardial infarction and stroke in adult patients at high risk for cardiovascular diseases such as coronary heart disease, diabetes, peripheral vascular disease, and stroke. It also reduces the risk that may occur after vascular interventions, protecting heart health. It is used in the treatment of hyperlipidemia, lowering bad cholesterol levels and raising good cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, thereby improving the balance of blood lipids. Particularly in patients with familial hypercholesterolemia and certain pediatric patients meeting specific criteria, it effectively lowers cholesterol levels when used in conjunction with a dietary regimen. This medication is used to reduce the risk of cardiovascular disease and improve hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. A dose of 5 ~ 40 mg of this drug once daily in the evening is recommended. Adjust the dose appropriately according to the baseline LDL cholesterol level before treatment, the treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of this drug at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). 2) For recommended doses in patients taking this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment), see below (see Precautions for Use, 6. Interactions). (1) Administration to patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this drug once daily in the evening. This drug should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are unavailable. (2) In older adults, a daily dose of 20 mg of this drug may achieve the maximum reduction in cholesterol levels. (3) Administration to patients taking verapamil, diltiazem, or dronedarone When this drug is administered concomitantly to patients taking verapamil, diltiazem, or dronedarone, the dose of this drug should not exceed 10 mg daily. (4) Administration to patients taking amiodarone, amlodipine, or ranolazine When this drug is administered concomitantly to patients taking amiodarone, amlodipine, or ranolazine, the dose of this drug should not exceed 20 mg daily. (5) Concomitant administration with other lipid-lowering agents This drug is effective when administered alone or in combination with a bile acid sequestrant. When this drug is administered concomitantly with a fibrate (excluding gemfibrozil (see Precautions for Use, 2. Patients in Whom the Drug Must Not Be Used) and fenofibrate), the dose of this drug should not exceed 10 mg daily. (6) Administration to patients with renal impairment Since this drug is not substantially excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg once daily and monitor closely.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg daily; the recommended maximum dose is 40 mg daily.
This medication primarily acts in the liver to lower blood cholesterol levels. However, it can cause muscle abnormalities, so if symptoms such as muscle pain or weakness occur during treatment, it must be reported to a doctor immediately. In particular, high-dose administration increases the risk of myopathy and rhabdomyolysis. This medication can affect liver function, thus it is safer not to use it in patients with liver disease or who have abnormally high liver enzyme levels. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication, and it should be discontinued immediately upon confirmation of pregnancy during treatment. There is a high potential for interaction with other medications, particularly with certain antifungals, antibiotics, immunosuppressants, calcium channel blockers, and some heart medications. It is advisable to avoid grapefruit juice during treatment and limit alcohol intake for liver health. Elderly patients, those with kidney or thyroid dysfunction, and patients with a history of muscle disease require careful monitoring when taking this medication. Regular blood tests to check liver function and muscle enzyme levels are recommended, and if abnormal findings are detected, consulting a physician is essential. This medication is not recommended for children under 10 years old or premenarche females. When taking this medication, it is important to inform the doctor or pharmacist about all currently taken medications, and to inform them when starting new medications. In the case of overdose, seek immediate medical treatment, and store this medication out of the reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication for a longer period.
Brownish yellow oval film-coated tablets
Packaging unit - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.